November 24, 2021
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
December 6, 2021
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
September 17, 2015
More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot…
October 17, 2019
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
November 12, 2021
…the randomized, double-blind, placebo-controlled clinical trial. Three trials are currently recruiting for between 66 and 80 patients who have tested positive for SARS-CoV-2 and who are quarantined at home with mild to moderate symptoms. Two are Food and Drug Administration (FDA)-approved Phase 1 clinical safety trials for investigational compounds to…
July 24, 2020
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
September 9, 2014
Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a stem cell-derived therapy for patients with Type 1 diabetes.
November 12, 2020
…the cost of current clinical COVID-19 tests. The project also will involve finding new ways to communicate with persons and communities of color who have long suffered from health inequities and lack of resources due to systemic racism. Dr. Susan Little, professor of medicine at UC San Diego School of…
May 4, 2020
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
October 6, 2022
Growing up, Rady School of Management alumna Katie Baca-Motes (MBA, ‘09) saw firsthand the devastating impact of limited health care access on her Hispanic father’s side of the family.
